CAMPA, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 12.124
AS - Asia 5.568
EU - Europa 3.986
SA - Sud America 1.118
AF - Africa 251
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 6
Totale 23.077
Nazione #
US - Stati Uniti d'America 11.822
SG - Singapore 1.772
CN - Cina 1.492
IT - Italia 1.294
HK - Hong Kong 1.174
BR - Brasile 919
DE - Germania 643
SE - Svezia 495
VN - Vietnam 430
BG - Bulgaria 382
FI - Finlandia 218
GB - Regno Unito 213
CA - Canada 206
RU - Federazione Russa 205
FR - Francia 149
KR - Corea 128
TR - Turchia 128
IN - India 117
AT - Austria 97
AR - Argentina 85
CI - Costa d'Avorio 77
UA - Ucraina 61
BD - Bangladesh 53
JP - Giappone 46
MA - Marocco 45
EC - Ecuador 40
MX - Messico 40
IQ - Iraq 39
ZA - Sudafrica 37
SN - Senegal 35
PK - Pakistan 33
IE - Irlanda 31
BE - Belgio 27
NL - Olanda 26
SA - Arabia Saudita 25
PL - Polonia 23
CO - Colombia 21
ID - Indonesia 20
UZ - Uzbekistan 20
AU - Australia 19
EE - Estonia 19
ES - Italia 18
CZ - Repubblica Ceca 14
VE - Venezuela 14
CH - Svizzera 13
PY - Paraguay 13
EG - Egitto 11
GR - Grecia 11
JM - Giamaica 11
HU - Ungheria 10
MY - Malesia 10
CR - Costa Rica 9
TN - Tunisia 9
CL - Cile 8
DZ - Algeria 8
LB - Libano 8
IL - Israele 7
LT - Lituania 7
UY - Uruguay 7
JO - Giordania 6
KE - Kenya 6
NG - Nigeria 6
NP - Nepal 6
OM - Oman 6
PA - Panama 6
AL - Albania 5
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
NZ - Nuova Zelanda 5
PE - Perù 5
PS - Palestinian Territory 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
ET - Etiopia 4
EU - Europa 4
IR - Iran 4
KZ - Kazakistan 4
PH - Filippine 4
SV - El Salvador 4
AO - Angola 3
BO - Bolivia 3
GT - Guatemala 3
KG - Kirghizistan 3
QA - Qatar 3
AM - Armenia 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
Totale 23.045
Città #
Ashburn 1.349
Woodbridge 1.215
Fairfield 1.179
Hong Kong 1.164
Singapore 1.007
Dallas 954
Houston 759
Ann Arbor 749
Santa Clara 645
Chandler 557
Seattle 471
Shanghai 409
Wilmington 408
Sofia 381
Cambridge 367
New York 301
Beijing 279
Boardman 266
Milan 249
Serra 217
Hefei 191
Munich 187
Princeton 175
Los Angeles 156
Lawrence 149
Ottawa 149
Medford 146
Florence 124
Seoul 117
Des Moines 112
Frankfurt am Main 109
Bremen 107
Pisa 97
Redondo Beach 85
Dong Ket 78
Abidjan 77
Nuremberg 77
Ho Chi Minh City 76
Nanjing 73
Rome 73
Buffalo 70
São Paulo 67
San Diego 66
Vienna 65
Istanbul 61
London 59
Helsinki 58
Hanoi 54
Jacksonville 54
Dearborn 47
Falls Church 41
Lappeenranta 40
Ogden 37
Rio de Janeiro 37
Dakar 35
Izmir 35
Phoenix 35
Casablanca 34
Tokyo 31
Lucca 30
Council Bluffs 28
Boulder 25
Brussels 25
Düsseldorf 25
Guangzhou 25
Toronto 25
Nanchang 24
Redwood City 24
Turku 24
Changsha 23
Pune 23
The Dalles 23
Chicago 22
Hyderabad 22
Fuzhou 21
San Francisco 21
Guarulhos 20
Marseille 20
Shenyang 20
Warsaw 20
Quito 19
Brasília 18
Curitiba 18
Jiaxing 18
Orem 18
Belo Horizonte 17
Tashkent 17
Columbus 16
Genoa 16
Norwalk 16
Johannesburg 15
Manchester 15
Salvador 15
Baghdad 14
Hebei 14
Mexico City 14
Amsterdam 13
Dhaka 12
Goiânia 12
Kent 12
Totale 17.009
Nome #
Maternal anthropometric variables and clinical factors shape neonatal microbiome 313
Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium 282
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer 246
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief 231
Global diversity in the TAS2R38 bitter taste receptor: revisiting a classic evolutionary PROPosal 227
Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk 208
A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer 203
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes 197
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). 192
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. 192
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk 191
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer 188
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. 187
Association between TAS2R38 gene polymorphisms and colorectal cancer risk: a case-control study in two independent populations of Caucasian origin 185
Outcome of experimental rat vaginitis by Candida albicans isolates with different karyotypes 175
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. 174
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. 172
Association between taste receptor (TAS) genes and the perception of wine characteristics 170
MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotyping 163
A gene-wide investigation on polymorphisms in the taste receptor 2R14 (TAS2R14) and susceptibility to colorectal cancer 162
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 161
Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma 160
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. 157
Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin. 157
Single nucleotide polymorphism detection by optical DNA-based sensing coupled with whole genomic amplification. 155
Bitter taste receptor polymorphisms and human aging. 152
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis 151
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. 151
Two susceptibility loci identified for prostate cancer aggressiveness. 150
Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 149
Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study. 149
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study 149
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 148
Population-specific association of genes for telomere-associated proteins with longevity in an Italian population 147
Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort 146
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. 145
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes 145
Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. 144
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. 144
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients 144
Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. 143
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 143
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 142
Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. 142
A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer. 142
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer 142
Pancreatic cancer susceptibility loci and their role in survival. 141
CD69, a New Potential Clinical Marker in Multiple Myeloma 141
Genetic risk variants associated with in situ breast cancer 141
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 141
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. 141
DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses 140
Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study 139
POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors. 138
Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. 137
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. 137
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 137
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. 136
Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer 136
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. 135
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 135
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. 135
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). 134
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. 134
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 132
Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection 131
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. 131
Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). 131
Common germline polymorphisms associated with breast cancer-specific survival. 131
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk 131
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 130
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis 130
Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). 130
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians 129
Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. 129
Lack of association between polymorphisms in inflammatory genes and lung cancer risk. 127
Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. 127
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79 000 women. 126
Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci? 125
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 124
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. 124
Role of OPRM1, clinical and anthropometric variants in neonatal pain reduction 124
Germline genetic variability in pancreatic cancer risk and prognosis 124
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 123
Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk. 123
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 123
Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms 122
Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer 121
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma 121
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers 120
A genome-wide pleiotropy scan for prostate cancer risk. 120
A polygenic risk score for multiple myeloma risk prediction 120
Genetic association of gastric cancer with miRNA clusters including the cancer-related genesMIR29, MIR25, MIR93andMIR106: Results from the EPIC-EURGAST study 120
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 119
Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. 119
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 118
Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium. 118
Somatic mutations in exocrine pancreatic tumors: association with patient survival. 117
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. 117
Leukocyte telomere length in relation to pancreatic cancer risk: A prospective study 117
Totale 14.868
Categoria #
all - tutte 71.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021978 0 0 0 0 0 58 188 122 167 95 83 265
2021/20221.837 43 114 57 99 315 229 82 84 160 82 102 470
2022/20232.012 256 199 112 234 211 233 22 154 365 12 191 23
2023/20241.691 134 157 197 77 240 312 49 64 40 40 163 218
2024/20255.996 12 200 113 256 443 698 534 352 609 851 678 1.250
2025/20264.623 566 952 1.140 743 646 576 0 0 0 0 0 0
Totale 23.822